pharma · Pulmonary Hypertension Associated with Interstitial Lung Disease · Pulmonary Arterial Hypertension
Insmed Incorporated
Insmed Limited
Insmed Incorporated clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Bridgewater Township, USA
- Employees
- 1,666
- Programs
- 7
- Drugs
- 18
- Patents
- 0
Insmed Incorporated projects
4 ClinicalTrials.gov programs sponsored by Insmed Incorporated.
Insmed Incorporated has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
INS-416
Insmed Limited
"Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)"
1 trial -
INS1009-203
Insmed Limited
Pulmonary Arterial Hypertension
1 trial -
INS1009-212
Insmed Limited
Pulmonary Hypertension Associated with Interstitial Lung Disease
1 trial -
INS1009-311
Insmed Limited
Pulmonary Hypertension Associated with Interstitial Lung Disease
1 trial
Frequently asked questions
How many clinical projects does Insmed Incorporated have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.